A medical device company in the United States is trying to fill the gap for patients who cannot afford insulin.
Invis align will replace insulin for $10 per month, according to The New York Times.
Insulin is one of the most effective forms of insulin treatment for people with type 2 diabetes, and it can save up to 30 percent on insulin treatment.
The company is hoping to sell the device to people who can’t afford it and has raised $5 million from a number of investors including Google Ventures, Intel Capital, and the Sequoia Capital Fund.
It will also be selling the device for $12.99 a month, which is below the cost of a monthly insulin prescription.
A lot of people are taking insulin as a substitute for insulin injections, and many of them will find it difficult to find a doctor who can prescribe it.
Insolitex, a company that uses insulin as an alternative to insulin injections in the US, launched its Insulin Doctor in September.
It charges $8 per month and has been gaining attention as a way for people to save money on their insulin prescription while still being able to get the treatment they need.
However, Insolix has struggled with a shortage of doctors.
In September, Insulix announced that it had lost $3 million in the first three months of the year, and that it will only have 5,000 physicians practicing at the end of this year.
Insullex will be launching a new diabetes management platform in the fall.
“This is a huge opportunity for us,” Insulx CEO and cofounder Scott Aiken said in a statement.
“The next generation of diabetes management is here.”
Insulin’s future is uncertain because it has a large price tag, so the company is launching the Insulin Doctors Rental program to try and get in front of potential customers.
The program will have doctors who can take on patients and provide their own insulin prescriptions, and they will also provide patients with the services of a doctor for free.
Insula, a healthcare company in China, has also raised $100 million to launch its own insulin doctor.
In February, a new generation of insulin medications became available in China.
Some patients may not be able to afford the cost or insurance premiums associated with the new medications, and this is why they have a need for insulin, but they don’t have access to a doctor.
If Insula can help these patients get insulin, it will help other patients as well.